Chicago Health | Homepage
Many ways to lower cholesterol will reduce heart disease risk

Many ways to lower cholesterol will reduce heart disease risk

Harvard Health Blog

By Deepak Bhatt, M.D., M.P.H.

Several contemporary clinical trials have shown that cholesterol-lowering statin drugs reduce the risk of heart attacks in patients with coronary artery disease. This compelling body of evidence has led to the question of whether other drugs that lower cholesterol also reduce heart attacks. Older studies had certainly shown this, though these studies were from an era prior to widespread statin use. A recent study showed that in patients with a mild heart attack, adding ezetimibe — a drug that interferes with cholesterol absorption from the intestines — to a statin reduced cardiovascular risk compared with a statin alone.

Now, a carefully done meta-analysis synthesizes all the studies to date and provides some new insights. A meta-analysis is a way of combining data from many studies over several years and analyzing the data to provide a bottom-line message. This particular meta-analysis consisted of data drawn from 49 studies of a total of 312,175 patients, a staggering number. The authors included only randomized clinical trials — the most rigorous type of study — and went back all the way to 1966 in their search for relevant trials.

The degree of benefit provided by statin and certain non-statin approaches that work predominantly by increasing the number of receptors in the body to clear out LDL cholesterol was roughly similar. The non-statin approaches included diet, bile acid sequestrants, ezetimibe, and ileal bypass surgery. Additional non-statin drugs assessed included niacin and fibrates. Both types of drugs offered cardiovascular risk reduction as well, though a major caveat regarding the data supporting use of these non-statin drugs was that the trials were not done on top of statins, or did not show clear benefits when added to statins.

Another important observation in this analysis was that lower levels of achieved LDL cholesterol were associated with even lower rates of major coronary events. This held true both for secondary prevention (that is, in patients with known atherosclerosis) as well as for primary prevention (that is, in patients with elevated cholesterol and cardiovascular risk, but without apparent atherosclerosis). The data drawn from the recent studies of the potent injectable PCSK9 inhibitor drugs also seem to support the relationship of lower cholesterol levels being more beneficial. However, it should be noted that large cardiovascular outcome trials are ongoing with these expensive injectable agents, to see if in fact they do decrease heart attack rates to the extent predicted from the large reductions in cholesterol they produce.

Thus, it appears that a variety of methods to lower cholesterol — several drugs and also diet — lower cardiovascular events, such as the chances of developing a heart attack. For patients at high cardiovascular risk, in addition to a healthy diet, statins remain the first-line drug therapy. For patients who cannot tolerate statins, non-statin drugs, including some of the older drugs, may provide a reasonable degree of benefit. The answer to whether even lower degrees of cholesterol reduction achieved by PCSK9 inhibitors further decrease cardiovascular risk is eagerly awaited.

Deepak Bhatt, M.D., M.P.H., is editor-in-chief of Harvard Heart Letter.
(C) 2016. PRESIDENT AND FELLOWS OF HARVARD COLLGE. ALL RIGHTS RESERVED. DISTRIBUTED BY TRIBUNE CONTENT AGENCY, LLC.

Similar Articles

Make your diet more nutrient-dense

Make your diet more nutrient-dense

Environmental Nutrition By Matthew Kadey, M.S., R.D., Environmental Nutrition Newsletter There is only so much food you

Gluten related symptoms: Celiac disease or gluten sensitivity?

Gluten related symptoms: Celiac disease or gluten sensitivity?

The Medicine Cabinet: Ask the Harvard Experts By Howard LeWine, M.D. Q: I seem to be very

Start treatment now to prevent spring allergy symptoms

Start treatment now to prevent spring allergy symptoms

The Medicine Cabinet: Ask the Harvard Experts By Howard LeWine, M.D. Q: I have spring allergies. Every

Does your doctor’s gender matter?

Does your doctor’s gender matter?

By Robert H. Shmerling, M.D. Harvard Health Blog I've read medical research studies that surprised me. I've

10 tips to fight osteoporosis

10 tips to fight osteoporosis

Environmental Nutrition By Carrie Dennett, M.P.H., R.D.N., Environmental Nutrition Newsletter Because 70 percent of our bone destiny

Articles By Category

Family Health

In The Know

CH Lifestyle

May 2017
Sunday Monday Tuesday Wednesday Thursday Friday Saturday
April 30, 2017 May 1, 2017 May 2, 2017 May 3, 2017 May 4, 2017 May 5, 2017 May 6, 2017
May 7, 2017 May 8, 2017 May 9, 2017 May 10, 2017 May 11, 2017 May 12, 2017 May 13, 2017
May 14, 2017 May 15, 2017 May 16, 2017 May 17, 2017 May 18, 2017 May 19, 2017 May 20, 2017
May 21, 2017 May 22, 2017 May 23, 2017 May 24, 2017 May 25, 2017 May 26, 2017 May 27, 2017
May 28, 2017 May 29, 2017 May 30, 2017 May 31, 2017 June 1, 2017 June 2, 2017 June 3, 2017

Categories

Recent Comments

Fund a Cure Night | The Griffith Family Foundation

Fund a Cure Night | The Griffith Family Foundation

Enjoy a great night of baseball at Peoples Natural

VIEW ARTICLE
Swing for the fences in the fight to Sideline Pancreatic Cancer

Swing for the fences in the fight to Sideline Pancreatic Cancer

Enjoy a great night of baseball at Peoples Natural

VIEW ARTICLE

Archives